May 25th, 2020 - As Thomas Powles, MD, PhD, of Queen Mary University of London, prepares to deliver his late-breaking presentation at the ASCO20 Virtual Scientific Program (LBA-1), he talks with Christopher Sweeney, MBBS, of Dana-Farber Cancer Institute, about current therapy: PD1/PDL1 inhibition in second-line treatment and as monotherapy in the first-line setting, as well as the concept of maintenance switch.
https://meetinglibrary.asco.org/browse-meetings/2020 ASCO Virtual Scientific Program
Abstract titles for each of the scientific tracks for ASCO 2020.
May 20th, 2020
May 13th, 2020 - Women with platinum-sensitive relapsed ovarian cancer and a BRCA mutation could see their survival extended by over a year by maintenance therapy with the PARP-inihibitor olaparib (Lynparza, AstraZeneca).
May 13th, 2020 - Use of comprehensive geriatric assessment and integration of geriatrician-led management into care plans improved health-related quality of life for older adults receiving systemic anticancer therapy, according to results of the prospective, randomized INTEGERATE trial scheduled for presentation during the ASCO20 Virtual Scientific Program.
May 13th, 2020 - Quitting smoking prior to a lung cancer diagnosis is associated with a survival benefit, even among patients who recently stopped smoking, according to results of a pooled analysis.
May 13th, 2020 - States that expanded Medicaid under the Affordable Care Act witnessed significant declines in cancer mortality rates compared with states that did not expand Medicaid, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.
May 13th, 2020 - Women with relapsed, platinum-sensitive ovarian cancer associated with BRCA mutations lived more than a year longer if they received olaparib (Lynparza) following chemotherapy, data from a randomized trial showed.
May 13th, 2020 - Anxiety and distress related to caring for a cancer patient who lives far away may be alleviated through an intervention that includes video-based coaching sessions with a nurse practitioner or social worker, a randomized study suggests.
May 12th, 2020 - People who quit smoking prior to a lung cancer diagnosis demonstrated considerably reduced risk for death due to all causes compared with those who continued to smoke, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.
May 12th, 2020 - Maintenance therapy with olaparib extended OS compared with placebo among women with platinum-sensitive, BRCA-mutated relapsed ovarian cancer, according to the final analysis of the randomized phase 3 SOLO-2 study scheduled for presentation during the ASCO20 Virtual Scientific Program.
May 12th, 2020 - Medicaid expansion under the Affordable Care Act (ACA) was associated with reduced mortality rates among cancer patients, a large retrospective analysis found.
May 12th, 2020 - Maintenance treatment with olaparib (Lynparza) demonstrated an improved median overall survival (OS) of 12.9 months over placebo in patients with platinum-sensitive relapsed ovarian cancer harboring a BRCA1/2 mutation, according to final OS results from the phase III SOLO2/ENGOT-ov21 trial.
May 12th, 2020 - The cancer mortality rate declined more in states that expanded Medicaid coverage than those that didn’t follow the passage of the Affordable Care Act (ACA) of 2010, a study found. The data were presented during a press cast in advance of the 2020 American Society of Clinical Oncology (ASCO) Meeting, set for May 29-31. Researchers will present their findings during the meeting’s virtual scienti...
May 12th, 2020 - Treatment with olaparib (Lynparza) in the maintenance setting extended overall survival (OS) by 12.9 months in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations, compared with placebo, according to randomized phase 3 trial results presented during a 2020 ASCO Virtual Scientific Program press briefing.
May 12th, 2020 - People who quit smoking at any time, even up to 2 years before a lung cancer diagnosis, have increased chances of survival after their diagnosis, according to data during a 2020 ASCO Virtual Scientific Program press briefing.
May 12th, 2020 - Distance caregivers of patients with cancer reported significant reductions in anxiety and distress after completing a series of coaching sessions via videoconference, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.
May 12th, 2020 - The use of video conference technology significantly reduced anxiety and stress among individuals who provide care for an individual with cancer and live more than one hour away from the patient, according to data from a randomized controlled trial presented during a 2020 ASCO Virtual Scientific Program press briefing.
May 12th, 2020 - Integration of a comprehensive geriatric assessment with geriatrician-led management care improved health-related quality of life (HRQOL), unplanned hospital admissions, and treatment discontinuation among older adults undergoing systemic therapy for their cancer, according to results from the INTEGERATE study presented during a 2020 ASCO Virtual Scientific Program press briefing.
Awards presented at ASCO20